Streamex Corp. — Director's Dealing 2019

May 22, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2019-05-17

Reporting Person: ZELDIS JEROME B (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value per share	68709	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$9.975	2025-04-09	Common Stock (120000)		Direct
Options to Purchase Common Stock	$6.325	2025-06-22	Common Stock (20000)		Direct
Options to Purchase Common Stock	$3.40	2026-12-22	Common Stock (20000)		Direct
Series C Preferred Stock	$3.75		Common Stock (13334)		Direct
Warrants to Purchase Common Stock	$6.85	2021-08-17	Common Stock (1097)		Direct

Footnotes

F1: The options vested in 12 consecutive monthly installments beginning one month from June 22, 2015, the date of the grant. As of the date of this report, the options are fully vested and exercisable.

F2: The Series C Preferred Stock may be converted at any time at the option of the holder into shares of common stock at a conversion price of $3.75 per share. The Series C Preferred Stock has no expiration date.

F3: Each share of the Series C Preferred Stock is entitled to a nine percent (9%) annual dividend on the $1,000 per share stated value. Unless the Series C Preferred Stock is converted into shares of common stock, the dividends shall accrue and be payable in cash or, at the Issuer's option and subject to the satisfaction of certain conditions, in pay-in-kind shares. Such cumulative dividends are payable quarterly, commencing on September 30, 2013, thereafter quarterly on December 31, March 31, June 30 and September 30, and on each conversion date.

F4: The warrants were issued on August 17, 2018, and are exercisable as of the date of this report.